Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-043873

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mary Z. Luo
Officer — COO,Chief Scientist & Chairman · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Scientific Officer · Director · 10% Owner
Period of report
Jul 2, 2018
Accepted (ET)
Jul 3, 2018 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJul 2, 2018M319,791$12.023A2,400,410D
Common StockJul 2, 2018F284,516$15.39D2,115,894D
Common StockF1Jul 2, 2018M186,545$12.023A1,532,674ISee footnote
Common StockF1Jul 2, 2018F165,968$15.39D1,366,706ISee footnote
Common StockF2holding———7,461,594ISee footnote
Common StockF3holding———5,000ISee footnote
Common StockF4holding———200,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F5$12.023Jul 2, 2018M319,791D—Jul 5, 2018Common Stock319,7910D
Employee Stock Option (right to buy)F1,F5$12.023Jul 2, 2018M186,545D—Jul 5, 2018Common Stock186,5450I

Explanation of responses